APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Clinical trial NCT03175224 · RECRUITING

Trial details

NCT number: NCT03175224
Sponsor: Apollomics Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumors Advanced Cancer Renal Cancer Gastric Cancer Gastroesophageal Junction Adenocarcinoma NSCLC Lung Cancer Brain Tumor Glioblastoma Multiforme EGFR Gene Mutation MET Amplification HGF

Start date: 2017-09-27
Primary completion: 2026-03-30
Enrollment: 497

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.